サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1361906

世界の医療用FLT3阻害剤市場：実績と予測 (2018年～2029年) メーカー別、主要地域別、タイプ別、アプリケーション別の詳細データ

Global Medical FLT3 Inhibitor Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
出版日: | 発行: QYResearch | ページ情報: 英文 101 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の医療用FLT3阻害剤市場：実績と予測 (2018年～2029年) メーカー別、主要地域別、タイプ別、アプリケーション別の詳細データ
出版日: 2023年10月17日
発行: QYResearch
ページ情報: 英文 101 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、医療用FLT3阻害剤 (Medical FLT3 Inhibitor) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 医療用FLT3阻害剤 市場の事業概要

  • 医療用FLT3阻害剤 製品概要
  • 医療用FLT3阻害剤 市場 セグメントタイプ別
    • Type 1 FLT3 Inhibitors
    • Type 2 FLT3 Inhibitors
  • 世界の医療用FLT3阻害剤 市場規模：タイプ別
    • 世界の医療用FLT3阻害剤 市場規模の事業概要 タイプ別 (2018-2029)
    • Global Medical FLT3 Inhibitor Historic Market Size Review by Type (2018-2023)
    • Global Medical FLT3 Inhibitor Forecasted Market Size by Type (2024-2029)
  • 主要地域別 市場規模 セグメントタイプ別
    • 北米の医療用FLT3阻害剤 売上 内訳 タイプ別 (2018-2023)
    • Europe Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)
    • Asia-Pacific Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)
    • Latin America Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)
    • Middle East and Africa Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)

第2章 世界の医療用FLT3阻害剤市場

  • 世界トップ企業 医療用FLT3阻害剤 売上 (2018-2023)
  • 世界トップ企業 医療用FLT3阻害剤 収益 (2018-2023)
  • 世界トップ企業 医療用FLT3阻害剤 価格 (2018-2023)
  • 世界の企業 医療用FLT3阻害剤の製造拠点分布, 販売地域,の製品タイプ
  • 医療用FLT3阻害剤 市場 競合の状況と動向
    • 医療用FLT3阻害剤の市場：濃度別 (2018-2023)
    • 世界の5大・10大企業 医療用FLT3阻害剤 売上高と収益 in 2022
  • 世界の企業 企業タイプ別 (Tier 1, Tier 2 and Tier 3) & (売上高に基づいた in 医療用FLT3阻害剤 (2022年時点))
  • 主要企業の参入時期 医療用FLT3阻害剤 市場
  • 主要企業 医療用FLT3阻害剤 取扱商品
  • M&A、事業拡大

第3章 医療用FLT3阻害剤 地域別の現状と展望

  • 世界の医療用FLT3阻害剤 地域別市場規模および平均年間成長率: 2018 VS 2022 VS 2029
  • 世界の医療用FLT3阻害剤の市場規模実績：地域別
    • 世界の医療用FLT3阻害剤 売上：地域別 (2018-2023)
    • 世界の医療用FLT3阻害剤 売上：地域別 (2018-2023)
    • 世界の医療用FLT3阻害剤 売上 (数量と金額) 価格と売上総利益 (2018-2023)
  • 世界の医療用FLT3阻害剤の市場規模予測：地域別
    • 世界の医療用FLT3阻害剤 売上：地域別 (2024-2029)
    • 世界の医療用FLT3阻害剤 売上：地域別 (2024-2029)
    • 世界の医療用FLT3阻害剤 売上（数量・金額）価格、粗利率 (2024-2029)

第4章 世界の医療用FLT3阻害剤 用途別

  • 医療用FLT3阻害剤 市場セグメント：用途別
    • 病院
    • 研究室
    • その他
  • 世界の医療用FLT3阻害剤 市場規模：用途別
    • 世界の医療用FLT3阻害剤 市場規模概要：用途別 (2018-2029)
    • 世界の医療用FLT3阻害剤 市場規模の実績レビュー：用途別 (2018-2023)
    • 世界の医療用FLT3阻害剤の市場規模予測：用途別 (2024-2029)
  • 主要地域別 市場規模 用途別セグメント
    • 北米の医療用FLT3阻害剤 売上構成比：用途別 (2018-2023)
    • 欧州の医療用FLT3阻害剤 売上構成比：用途別 (2018-2023)
    • アジア太平洋地域 医療用FLT3阻害剤 売上構成比：用途別 (2018-2023)
    • ラテンアメリカの医療用FLT3阻害剤 売上構成比：用途別 (2018-2023)
    • 中東・アフリカの医療用FLT3阻害剤 売上構成比：用途別 (2018-2023)

第5章 北米の医療用FLT3阻害剤 国別

  • 北米の医療用FLT3阻害剤 市場規模の実績：国別
    • 北米の医療用FLT3阻害剤の市場規模成長率 (平均年間成長率) 国別: 2018 VS 2022 VS 2029
    • 北米の医療用FLT3阻害剤 売上：国別 (2018-2023)
    • 北米の医療用FLT3阻害剤 売上：国別 (2018-2023)
  • 北米の医療用FLT3阻害剤 市場規模の予測：国別
    • 北米の医療用FLT3阻害剤 売上：国別 (2024-2029)
    • 北米の医療用FLT3阻害剤 売上：国別 (2024-2029)

第6章 欧州の医療用FLT3阻害剤 国別

  • 欧州の医療用FLT3阻害剤 市場規模の実績：国別
    • 欧州の医療用FLT3阻害剤の市場規模成長率 (平均年間成長率) 国別: 2018 VS 2022 VS 2029
    • 欧州の医療用FLT3阻害剤 売上：国別 (2018-2023)
    • 欧州の医療用FLT3阻害剤 売上：国別 (2018-2023)
  • 欧州の医療用FLT3阻害剤 市場規模の予測：国別
    • 欧州の医療用FLT3阻害剤 売上：国別 (2024-2029)
    • 欧州の医療用FLT3阻害剤 売上：国別 (2024-2029)

第7章 アジア太平洋地域 医療用FLT3阻害剤 地域別

  • アジア太平洋地域 医療用FLT3阻害剤の市場規模実績：地域別
    • アジア太平洋地域 医療用FLT3阻害剤の市場規模成長率 (平均年間成長率) 地域別: 2018 VS 2022 VS 2029
    • アジア太平洋地域 医療用FLT3阻害剤 売上：地域別 (2018-2023)
    • アジア太平洋地域 医療用FLT3阻害剤 売上：地域別 (2018-2023)
  • アジア太平洋地域 医療用FLT3阻害剤の市場規模予測：地域別
    • アジア太平洋地域 医療用FLT3阻害剤 売上：地域別 (2024-2029)
    • アジア太平洋地域 医療用FLT3阻害剤 売上：地域別 (2024-2029)

第8章 ラテンアメリカの医療用FLT3阻害剤 国別

  • ラテンアメリカの医療用FLT3阻害剤 市場規模の実績：国別
    • ラテンアメリカの医療用FLT3阻害剤の市場規模成長率 (平均年間成長率) 国別: 2018 VS 2022 VS 2029
    • ラテンアメリカの医療用FLT3阻害剤 売上：国別 (2018-2023)
    • ラテンアメリカの医療用FLT3阻害剤 売上：国別 (2018-2023)
  • ラテンアメリカの医療用FLT3阻害剤 市場規模の予測：国別
    • ラテンアメリカの医療用FLT3阻害剤 売上：国別 (2024-2029)
    • ラテンアメリカの医療用FLT3阻害剤 売上：国別 (2024-2029)

第9章 中東・アフリカの医療用FLT3阻害剤 国別

  • 中東・アフリカの医療用FLT3阻害剤 市場規模の実績：国別
    • 中東・アフリカの医療用FLT3阻害剤の市場規模成長率 (平均年間成長率) 国別: 2018 VS 2022 VS 2029
    • 中東・アフリカの医療用FLT3阻害剤 売上：国別 (2018-2023)
    • 中東・アフリカの医療用FLT3阻害剤 売上：国別 (2018-2023)
  • 中東・アフリカの医療用FLT3阻害剤 市場規模の予測：国別
    • 中東・アフリカの医療用FLT3阻害剤 売上：国別 (2024-2029)
    • 中東・アフリカの医療用FLT3阻害剤 売上：国別 (2024-2029)

第10章 企業プロファイル

  • Cullinan Oncology
  • Novartis
  • Astellas Pharma
  • Daiichi Sankyo
  • AROG Pharmaceuticals
  • Allarity Therapeutics
  • FUJIFILM Pharmaceuticals
  • Aptose Biosciences
  • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
  • Jiangsu Hengrui Medicine

第11章 上流, 機会, 課題, リスクと影響要因の分析

  • 医療用FLT3阻害剤 主要原材料
    • 主要原材料
    • 主要原材料 価格
    • 原材料の主要サプライヤー
  • 製造コスト構造
    • 原材料
    • 人件費
    • 製造コスト
  • 医療用FLT3阻害剤 産業チェーン分析
  • 医療用FLT3阻害剤 市場動向
    • 医療用FLT3阻害剤 業界動向
    • 医療用FLT3阻害剤 市場の促進要因
    • 医療用FLT3阻害剤 市場の課題
    • 医療用FLT3阻害剤 市場の抑制要因

第12章 市場戦略分析、販売代理店

  • 販売チャネル
  • 医療用FLT3阻害剤 卸業者
  • 医療用FLT3阻害剤 下流顧客

第13章 市場調査結果と結論

第14章 付録

図表

List of Tables

  • Table 1. Major Company of Type 1 FLT3 Inhibitors
  • Table 2. Major Company of Type 2 FLT3 Inhibitors
  • Table 3. Global Medical FLT3 Inhibitor Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
  • Table 4. Global Medical FLT3 Inhibitor Sales by Type (2018-2023) & (K Units)
  • Table 5. Global Medical FLT3 Inhibitor Sales Market Share in Volume by Type (2018-2023)
  • Table 6. Global Medical FLT3 Inhibitor Sales by Type (2018-2023) & (US& Million)
  • Table 7. Global Medical FLT3 Inhibitor Market Share in Value by Type (2018-2023)
  • Table 8. Global Medical FLT3 Inhibitor Price by Type (2018-2023) & (US$/Unit)
  • Table 9. Global Medical FLT3 Inhibitor Sales by Type (2024-2029) & (K Units)
  • Table 10. Global Medical FLT3 Inhibitor Sales Market Share in Volume by Type (2024-2029)
  • Table 11. Global Medical FLT3 Inhibitor Sales by Type (2024-2029) & (US$ Million)
  • Table 12. Global Medical FLT3 Inhibitor Sales Market Share in Value by Type (2024-2029)
  • Table 13. Global Medical FLT3 Inhibitor Price by Type (2024-2029) & (US$/Unit)
  • Table 14. North America Medical FLT3 Inhibitor Sales by Type (2018-2023) & (K Units)
  • Table 15. North America Medical FLT3 Inhibitor Sales by Type (2018-2023) & (US$ Million)
  • Table 16. Europe Medical FLT3 Inhibitor Sales (K Units) by Type (2018-2023)
  • Table 17. Europe Medical FLT3 Inhibitor Sales by Type (2018-2023) & (US$ Million)
  • Table 18. Asia-Pacific Medical FLT3 Inhibitor Sales (K Units) by Type (2018-2023)
  • Table 19. Asia-Pacific Medical FLT3 Inhibitor Sales by Type (2018-2023) & (US$ Million)
  • Table 20. Latin America Medical FLT3 Inhibitor Sales (K Units) by Type (2018-2023)
  • Table 21. Latin America Medical FLT3 Inhibitor Sales by Type (2018-2023) & (US$ Million)
  • Table 22. Middle East and Africa Medical FLT3 Inhibitor Sales (K Units) by Type (2018-2023)
  • Table 23. Middle East and Africa Medical FLT3 Inhibitor Sales by Type (2018-2023) & (US$ Million)
  • Table 24. Global Medical FLT3 Inhibitor Sales by Company (2018-2023) & (K Units)
  • Table 25. Global Medical FLT3 Inhibitor Sales Share by Company (2018-2023)
  • Table 26. Global Medical FLT3 Inhibitor Revenue by Company (2018-2023) & (US$ Million)
  • Table 27. Global Medical FLT3 Inhibitor Revenue Share by Company (2018-2023)
  • Table 28. Global Market Medical FLT3 Inhibitor Price by Company (2018-2023) & (US$/Unit)
  • Table 29. Global Medical FLT3 Inhibitor Top Manufacturers Manufacturing Base Distribution and Sales Area
  • Table 30. Global Medical FLT3 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical FLT3 Inhibitor as of 2022)
  • Table 32. Date of Key Manufacturers Enter into Medical FLT3 Inhibitor Market
  • Table 33. Key Manufacturers Medical FLT3 Inhibitor Product Type
  • Table 34. Mergers & Acquisitions, Expansion Plans
  • Table 35. Global Medical FLT3 Inhibitor Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 36. Global Medical FLT3 Inhibitor Sales by Region (2018-2023) & (K Units)
  • Table 37. Global Medical FLT3 Inhibitor Sales Market Share in Volume by Region (2018-2023)
  • Table 38. Global Medical FLT3 Inhibitor Sales by Region (2018-2023) & (US$ Million)
  • Table 39. Global Medical FLT3 Inhibitor Sales Market Share in Value by Region (2018-2023)
  • Table 40. Global Medical FLT3 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 41. Global Medical FLT3 Inhibitor Sales by Region (2024-2029) & (K Units)
  • Table 42. Global Medical FLT3 Inhibitor Sales Market Share in Volume by Region (2024-2029)
  • Table 43. Global Medical FLT3 Inhibitor Sales by Region (2024-2029) & (US$ Million)
  • Table 44. Global Medical FLT3 Inhibitor Sales Market Share in Value by Region (2024-2029)
  • Table 45. Global Medical FLT3 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
  • Table 46. Global Medical FLT3 Inhibitor Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 47. Global Medical FLT3 Inhibitor Sales by Application (2018-2023) & (K Units)
  • Table 48. Global Medical FLT3 Inhibitor Sales Market Share in Volume by Application (2018-2023)
  • Table 49. Global Medical FLT3 Inhibitor Sales by Application (2018-2023) & (US$ Million)
  • Table 50. Global Medical FLT3 Inhibitor Sales Market Share in Value by Application (2018-2023)
  • Table 51. Global Medical FLT3 Inhibitor Price by Application (2018-2023) & (US$/Unit)
  • Table 52. Global Medical FLT3 Inhibitor Sales by Application (2024-2029) & (K Units)
  • Table 53. Global Medical FLT3 Inhibitor Sales Market Share in Volume by Application (2024-2029)
  • Table 54. Global Medical FLT3 Inhibitor Sales by Application (2024-2029) & (US$ Million)
  • Table 55. Global Medical FLT3 Inhibitor Sales Market Share in Value by Application (2024-2029)
  • Table 56. Global Medical FLT3 Inhibitor Price by Application (2024-2029) & (US$/Unit)
  • Table 57. North America Medical FLT3 Inhibitor Sales by Application (2018-2023) (K Units)
  • Table 58. North America Medical FLT3 Inhibitor Sales by Application (2018-2023) & (US$ Million)
  • Table 59. Europe Medical FLT3 Inhibitor Sales by Application (2018-2023) (K Units)
  • Table 60. Europe Medical FLT3 Inhibitor Sales by Application (2018-2023) & (US$ Million)
  • Table 61. Asia-Pacific Medical FLT3 Inhibitor Sales by Application (2018-2023) (K Units)
  • Table 62. Asia-Pacific Medical FLT3 Inhibitor Sales by Application (2018-2023) & (US$ Million)
  • Table 63. Latin America Medical FLT3 Inhibitor Sales by Application (2018-2023) (K Units)
  • Table 64. Latin America Medical FLT3 Inhibitor Sales by Application (2018-2023) & (US$ Million)
  • Table 65. Middle East and Africa Medical FLT3 Inhibitor Sales by Application (2018-2023) (K Units)
  • Table 66. Middle East and Africa Medical FLT3 Inhibitor Sales by Application (2018-2023) & (US$ Million)
  • Table 67. North America Medical FLT3 Inhibitor Sales by Country (2018-2023) & (K Units)
  • Table 68. North America Medical FLT3 Inhibitor Sales Market Share in Volume by Country (2018-2023)
  • Table 69. North America Medical FLT3 Inhibitor Sales by Country (2018-2023) & (US$ Million)
  • Table 70. North America Medical FLT3 Inhibitor Sales Market Share in Value by Country (2018-2023)
  • Table 71. North America Medical FLT3 Inhibitor Sales by Country (2024-2029) & (K Units)
  • Table 72. North America Medical FLT3 Inhibitor Sales Market Share in Volume by Country (2024-2029)
  • Table 73. North America Medical FLT3 Inhibitor Sales by Country (2024-2029) & (US$ Million)
  • Table 74. North America Medical FLT3 Inhibitor Sales Market Share in Value by Country (2024-2029)
  • Table 75. Europe Medical FLT3 Inhibitor Sales by Country (2018-2023) & (K Units)
  • Table 76. Europe Medical FLT3 Inhibitor Sales Market Share in Volume by Country (2018-2023)
  • Table 77. Europe Medical FLT3 Inhibitor Sales by Country (2018-2023) & (US$ Million)
  • Table 78. Europe Medical FLT3 Inhibitor Sales Market Share in Value by Country (2018-2023)
  • Table 79. Europe Medical FLT3 Inhibitor Sales by Country (2024-2029) & (K Units)
  • Table 80. Europe Medical FLT3 Inhibitor Sales Market Share in Volume by Country (2024-2029)
  • Table 81. Europe Medical FLT3 Inhibitor Sales by Country (2024-2029) & (US$ Million)
  • Table 82. Europe Medical FLT3 Inhibitor Sales Market Share in Value by Country (2024-2029)
  • Table 83. Asia-Pacific Medical FLT3 Inhibitor Sales by Region (2018-2023) & (K Units)
  • Table 84. Asia-Pacific Medical FLT3 Inhibitor Sales Market Share in Volume by Region (2018-2023)
  • Table 85. Asia-Pacific Medical FLT3 Inhibitor Sales by Region (2018-2023) & (US$ Million)
  • Table 86. Asia-Pacific Medical FLT3 Inhibitor Sales Market Share in Value by Region (2018-2023)
  • Table 87. Asia-Pacific Medical FLT3 Inhibitor Sales by Region (2024-2029) & (K Units)
  • Table 88. Asia-Pacific Medical FLT3 Inhibitor Sales Market Share in Volume by Region (2024-2029)
  • Table 89. Asia-Pacific Medical FLT3 Inhibitor Sales by Region (2024-2029) & (US$ Million)
  • Table 90. Asia-Pacific Medical FLT3 Inhibitor Sales Market Share in Value by Region (2024-2029)
  • Table 91. Latin America Medical FLT3 Inhibitor Sales by Country (2018-2023) & (K Units)
  • Table 92. Latin America Medical FLT3 Inhibitor Sales Market Share in Volume by Country (2018-2023)
  • Table 93. Latin America Medical FLT3 Inhibitor Sales by Country (2018-2023) & (US$ Million)
  • Table 94. Latin America Medical FLT3 Inhibitor Sales Market Share in Value by Country (2018-2023)
  • Table 95. Latin America Medical FLT3 Inhibitor Sales by Country (2024-2029) & (K Units)
  • Table 96. Latin America Medical FLT3 Inhibitor Sales Market Share in Volume by Country (2024-2029)
  • Table 97. Latin America Medical FLT3 Inhibitor Sales by Country (2024-2029) & (US$ Million)
  • Table 98. Latin America Medical FLT3 Inhibitor Sales Market Share in Value by Country (2024-2029)
  • Table 99. Middle East and Africa Medical FLT3 Inhibitor Sales by Country (2018-2023) & (K Units)
  • Table 100. Middle East and Africa Medical FLT3 Inhibitor Sales Market Share in Volume by Country (2018-2023)
  • Table 101. Middle East and Africa Medical FLT3 Inhibitor Sales by Country (2018-2023) & (US$ Million)
  • Table 102. Middle East and Africa Medical FLT3 Inhibitor Sales Market Share in Value by Country (2018-2023)
  • Table 103. Middle East and Africa Medical FLT3 Inhibitor Sales by Country (2024-2029) & (K Units)
  • Table 104. Middle East and Africa Medical FLT3 Inhibitor Sales Market Share in Volume by Country (2024-2029)
  • Table 105. Middle East and Africa Medical FLT3 Inhibitor Sales by Country (2024-2029) & (US$ Million)
  • Table 106. Middle East and Africa Medical FLT3 Inhibitor Sales Market Share in Value by Country (2024-2029)
  • Table 107. Cullinan Oncology Company Information
  • Table 108. Cullinan Oncology Introduction and Business Overview
  • Table 109. Cullinan Oncology Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 110. Cullinan Oncology Medical FLT3 Inhibitor Product
  • Table 111. Cullinan Oncology Recent Development
  • Table 112. Novartis Company Information
  • Table 113. Novartis Introduction and Business Overview
  • Table 114. Novartis Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 115. Novartis Medical FLT3 Inhibitor Product
  • Table 116. Novartis Recent Development
  • Table 117. Astellas Pharma Company Information
  • Table 118. Astellas Pharma Introduction and Business Overview
  • Table 119. Astellas Pharma Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 120. Astellas Pharma Medical FLT3 Inhibitor Product
  • Table 121. Astellas Pharma Recent Development
  • Table 122. Daiichi Sankyo Company Information
  • Table 123. Daiichi Sankyo Introduction and Business Overview
  • Table 124. Daiichi Sankyo Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 125. Daiichi Sankyo Medical FLT3 Inhibitor Product
  • Table 126. Daiichi Sankyo Recent Development
  • Table 127. AROG Pharmaceuticals Company Information
  • Table 128. AROG Pharmaceuticals Introduction and Business Overview
  • Table 129. AROG Pharmaceuticals Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 130. AROG Pharmaceuticals Medical FLT3 Inhibitor Product
  • Table 131. AROG Pharmaceuticals Recent Development
  • Table 132. Allarity Therapeutics Company Information
  • Table 133. Allarity Therapeutics Introduction and Business Overview
  • Table 134. Allarity Therapeutics Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 135. Allarity Therapeutics Medical FLT3 Inhibitor Product
  • Table 136. Allarity Therapeutics Recent Development
  • Table 137. FUJIFILM Pharmaceuticals Company Information
  • Table 138. FUJIFILM Pharmaceuticals Introduction and Business Overview
  • Table 139. FUJIFILM Pharmaceuticals Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 140. FUJIFILM Pharmaceuticals Medical FLT3 Inhibitor Product
  • Table 141. FUJIFILM Pharmaceuticals Recent Development
  • Table 142. Aptose Biosciences Company Information
  • Table 143. Aptose Biosciences Introduction and Business Overview
  • Table 144. Aptose Biosciences Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 145. Aptose Biosciences Medical FLT3 Inhibitor Product
  • Table 146. Aptose Biosciences Recent Development
  • Table 147. CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Company Information
  • Table 148. CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Introduction and Business Overview
  • Table 149. CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 150. CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Medical FLT3 Inhibitor Product
  • Table 151. CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Recent Development
  • Table 152. Jiangsu Hengrui Medicine Company Information
  • Table 153. Jiangsu Hengrui Medicine Introduction and Business Overview
  • Table 154. Jiangsu Hengrui Medicine Medical FLT3 Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 155. Jiangsu Hengrui Medicine Medical FLT3 Inhibitor Product
  • Table 156. Jiangsu Hengrui Medicine Recent Development
  • Table 157. Key Raw Materials Lists
  • Table 158. Raw Materials Key Suppliers Lists
  • Table 159. Medical FLT3 Inhibitor Market Trends
  • Table 160. Medical FLT3 Inhibitor Market Drivers
  • Table 161. Medical FLT3 Inhibitor Market Challenges
  • Table 162. Medical FLT3 Inhibitor Market Restraints
  • Table 163. Medical FLT3 Inhibitor Distributors List
  • Table 164. Medical FLT3 Inhibitor Downstream Customers
  • Table 165. Research Programs/Design for This Report
  • Table 166. Key Data Information from Secondary Sources
  • Table 167. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Medical FLT3 Inhibitor Product Picture
  • Figure 2. Global Medical FLT3 Inhibitor Market Size, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Medical FLT3 Inhibitor Market Size Status and Outlook (2018-2029) & (US$ Million)
  • Figure 4. Global Medical FLT3 Inhibitor Sales Status and Outlook (2018-2029) & (K Units)
  • Figure 5. Product Picture of Type 1 FLT3 Inhibitors
  • Figure 6. Global Type 1 FLT3 Inhibitors Sales YoY Growth (2018-2029) & (K Units)
  • Figure 7. Product Picture of Type 2 FLT3 Inhibitors
  • Figure 8. Global Type 2 FLT3 Inhibitors Sales YoY Growth (2018-2029) & (K Units)
  • Figure 9. Global Medical FLT3 Inhibitor Sales by Type (2018-2029) & (US$ Million)
  • Figure 10. Global Medical FLT3 Inhibitor Sales Market Share by Type in 2022 & 2029
  • Figure 11. North America Medical FLT3 Inhibitor Sales Market Share in Volume by Type in 2022
  • Figure 12. North America Medical FLT3 Inhibitor Sales Market Share in Value by Type in 2022
  • Figure 13. Europe Medical FLT3 Inhibitor Sales Market Share in Volume by Type in 2022
  • Figure 14. Europe Medical FLT3 Inhibitor Sales Market Share in Value by Type in 2022
  • Figure 15. Asia-Pacific Medical FLT3 Inhibitor Sales Market Share in Volume by Type in 2022
  • Figure 16. Asia-Pacific Medical FLT3 Inhibitor Sales Market Share in Value by Type in 2022
  • Figure 17. Latin America Medical FLT3 Inhibitor Sales Market Share in Volume by Type in 2022
  • Figure 18. Latin America Medical FLT3 Inhibitor Sales Market Share in Value by Type in 2022
  • Figure 19. Middle East and Africa Medical FLT3 Inhibitor Sales Market Share in Volume by Type in 2022
  • Figure 20. Middle East and Africa Medical FLT3 Inhibitor Sales Market Share in Value by Type in 2022
  • Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical FLT3 Inhibitor Sales in 2022
  • Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical FLT3 Inhibitor Revenue in 2022
  • Figure 23. Medical FLT3 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 24. Product Picture of Hospital
  • Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
  • Figure 26. Product Picture of Research Laboratory
  • Figure 27. Global Research Laboratory Sales YoY Growth (2018-2029) & (K Units)
  • Figure 28. Product Picture of Others
  • Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)
  • Figure 30. Global Medical FLT3 Inhibitor Sales by Application (2018-2029) & (US$ Million)
  • Figure 31. Global Medical FLT3 Inhibitor Sales Market Share by Application in 2022 & 2029
  • Figure 32. North America Medical FLT3 Inhibitor Sales Market Share in Volume by Application in 2022
  • Figure 33. North America Medical FLT3 Inhibitor Sales Market Share in Value by Application in 2022
  • Figure 34. Europe Medical FLT3 Inhibitor Sales Market Share in Volume by Application in 2022
  • Figure 35. Europe Medical FLT3 Inhibitor Sales Market Share in Value by Application in 2022
  • Figure 36. Asia-Pacific Medical FLT3 Inhibitor Sales Market Share in Volume by Application in 2022
  • Figure 37. Asia-Pacific Medical FLT3 Inhibitor Sales Market Share in Value by Application in 2022
  • Figure 38. Latin America Medical FLT3 Inhibitor Sales Market Share in Volume by Application in 2022
  • Figure 39. Latin America Medical FLT3 Inhibitor Sales Market Share in Value by Application in 2022
  • Figure 40. Middle East and Africa Medical FLT3 Inhibitor Sales Market Share in Value by Application in 2022
  • Figure 41. Key Raw Materials Price
  • Figure 42. Medical FLT3 Inhibitor Manufacturing Cost Structure
  • Figure 43. Medical FLT3 Inhibitor Industrial Chain Analysis
  • Figure 44. Channels of Distribution
  • Figure 45. Distributors Profiles
  • Figure 46. Bottom-up and Top-down Approaches for This Report
  • Figure 47. Data Triangulation
  • Figure 48. Key Executives Interviewed
目次

This research report focuses on the Medical FLT3 Inhibitor Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Medical FLT3 Inhibitor Market Overview

  • 1.1 Medical FLT3 Inhibitor Product Overview
  • 1.2 Medical FLT3 Inhibitor Market Segment by Type
    • 1.2.1 Type 1 FLT3 Inhibitors
    • 1.2.2 Type 2 FLT3 Inhibitors
  • 1.3 Global Medical FLT3 Inhibitor Market Size by Type
    • 1.3.1 Global Medical FLT3 Inhibitor Market Size Overview by Type (2018-2029)
    • 1.3.2 Global Medical FLT3 Inhibitor Historic Market Size Review by Type (2018-2023)
    • 1.3.3 Global Medical FLT3 Inhibitor Forecasted Market Size by Type (2024-2029)
  • 1.4 Key Regions Market Size Segment by Type
    • 1.4.1 North America Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)
    • 1.4.2 Europe Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)
    • 1.4.3 Asia-Pacific Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)
    • 1.4.4 Latin America Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)
    • 1.4.5 Middle East and Africa Medical FLT3 Inhibitor Sales Breakdown by Type (2018-2023)

2 Global Medical FLT3 Inhibitor Market Competition by Company

  • 2.1 Global Top Players by Medical FLT3 Inhibitor Sales (2018-2023)
  • 2.2 Global Top Players by Medical FLT3 Inhibitor Revenue (2018-2023)
  • 2.3 Global Top Players by Medical FLT3 Inhibitor Price (2018-2023)
  • 2.4 Global Top Manufacturers Medical FLT3 Inhibitor Manufacturing Base Distribution, Sales Area, Product Type
  • 2.5 Medical FLT3 Inhibitor Market Competitive Situation and Trends
    • 2.5.1 Medical FLT3 Inhibitor Market Concentration Rate (2018-2023)
    • 2.5.2 Global 5 and 10 Largest Manufacturers by Medical FLT3 Inhibitor Sales and Revenue in 2022
  • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical FLT3 Inhibitor as of 2022)
  • 2.7 Date of Key Manufacturers Enter into Medical FLT3 Inhibitor Market
  • 2.8 Key Manufacturers Medical FLT3 Inhibitor Product Offered
  • 2.9 Mergers & Acquisitions, Expansion

3 Medical FLT3 Inhibitor Status and Outlook by Region

  • 3.1 Global Medical FLT3 Inhibitor Market Size and CAGR by Region: 2018 VS 2022 VS 2029
  • 3.2 Global Medical FLT3 Inhibitor Historic Market Size by Region
    • 3.2.1 Global Medical FLT3 Inhibitor Sales in Volume by Region (2018-2023)
    • 3.2.2 Global Medical FLT3 Inhibitor Sales in Value by Region (2018-2023)
    • 3.2.3 Global Medical FLT3 Inhibitor Sales (Volume & Value) Price and Gross Margin (2018-2023)
  • 3.3 Global Medical FLT3 Inhibitor Forecasted Market Size by Region
    • 3.3.1 Global Medical FLT3 Inhibitor Sales in Volume by Region (2024-2029)
    • 3.3.2 Global Medical FLT3 Inhibitor Sales in Value by Region (2024-2029)
    • 3.3.3 Global Medical FLT3 Inhibitor Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Medical FLT3 Inhibitor by Application

  • 4.1 Medical FLT3 Inhibitor Market Segment by Application
    • 4.1.1 Hospital
    • 4.1.2 Research Laboratory
    • 4.1.3 Others
  • 4.2 Global Medical FLT3 Inhibitor Market Size by Application
    • 4.2.1 Global Medical FLT3 Inhibitor Market Size Overview by Application (2018-2029)
    • 4.2.2 Global Medical FLT3 Inhibitor Historic Market Size Review by Application (2018-2023)
    • 4.2.3 Global Medical FLT3 Inhibitor Forecasted Market Size by Application (2024-2029)
  • 4.3 Key Regions Market Size Segment by Application
    • 4.3.1 North America Medical FLT3 Inhibitor Sales Breakdown by Application (2018-2023)
    • 4.3.2 Europe Medical FLT3 Inhibitor Sales Breakdown by Application (2018-2023)
    • 4.3.3 Asia-Pacific Medical FLT3 Inhibitor Sales Breakdown by Application (2018-2023)
    • 4.3.4 Latin America Medical FLT3 Inhibitor Sales Breakdown by Application (2018-2023)
    • 4.3.5 Middle East and Africa Medical FLT3 Inhibitor Sales Breakdown by Application (2018-2023)

5 North America Medical FLT3 Inhibitor by Country

  • 5.1 North America Medical FLT3 Inhibitor Historic Market Size by Country
    • 5.1.1 North America Medical FLT3 Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 5.1.2 North America Medical FLT3 Inhibitor Sales in Volume by Country (2018-2023)
    • 5.1.3 North America Medical FLT3 Inhibitor Sales in Value by Country (2018-2023)
  • 5.2 North America Medical FLT3 Inhibitor Forecasted Market Size by Country
    • 5.2.1 North America Medical FLT3 Inhibitor Sales in Volume by Country (2024-2029)
    • 5.2.2 North America Medical FLT3 Inhibitor Sales in Value by Country (2024-2029)

6 Europe Medical FLT3 Inhibitor by Country

  • 6.1 Europe Medical FLT3 Inhibitor Historic Market Size by Country
    • 6.1.1 Europe Medical FLT3 Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 6.1.2 Europe Medical FLT3 Inhibitor Sales in Volume by Country (2018-2023)
    • 6.1.3 Europe Medical FLT3 Inhibitor Sales in Value by Country (2018-2023)
  • 6.2 Europe Medical FLT3 Inhibitor Forecasted Market Size by Country
    • 6.2.1 Europe Medical FLT3 Inhibitor Sales in Volume by Country (2024-2029)
    • 6.2.2 Europe Medical FLT3 Inhibitor Sales in Value by Country (2024-2029)

7 Asia-Pacific Medical FLT3 Inhibitor by Region

  • 7.1 Asia-Pacific Medical FLT3 Inhibitor Historic Market Size by Region
    • 7.1.1 Asia-Pacific Medical FLT3 Inhibitor Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
    • 7.1.2 Asia-Pacific Medical FLT3 Inhibitor Sales in Volume by Region (2018-2023)
    • 7.1.3 Asia-Pacific Medical FLT3 Inhibitor Sales in Value by Region (2018-2023)
  • 7.2 Asia-Pacific Medical FLT3 Inhibitor Forecasted Market Size by Region
    • 7.2.1 Asia-Pacific Medical FLT3 Inhibitor Sales in Volume by Region (2024-2029)
    • 7.2.2 Asia-Pacific Medical FLT3 Inhibitor Sales in Value by Region (2024-2029)

8 Latin America Medical FLT3 Inhibitor by Country

  • 8.1 Latin America Medical FLT3 Inhibitor Historic Market Size by Country
    • 8.1.1 Latin America Medical FLT3 Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 8.1.2 Latin America Medical FLT3 Inhibitor Sales in Volume by Country (2018-2023)
    • 8.1.3 Latin America Medical FLT3 Inhibitor Sales in Value by Country (2018-2023)
  • 8.2 Latin America Medical FLT3 Inhibitor Forecasted Market Size by Country
    • 8.2.1 Latin America Medical FLT3 Inhibitor Sales in Volume by Country (2024-2029)
    • 8.2.2 Latin America Medical FLT3 Inhibitor Sales in Value by Country (2024-2029)

9 Middle East and Africa Medical FLT3 Inhibitor by Country

  • 9.1 Middle East and Africa Medical FLT3 Inhibitor Historic Market Size by Country
    • 9.1.1 Middle East and Africa Medical FLT3 Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
    • 9.1.2 Middle East and Africa Medical FLT3 Inhibitor Sales in Volume by Country (2018-2023)
    • 9.1.3 Middle East and Africa Medical FLT3 Inhibitor Sales in Value by Country (2018-2023)
  • 9.2 Middle East and Africa Medical FLT3 Inhibitor Forecasted Market Size by Country
    • 9.2.1 Middle East and Africa Medical FLT3 Inhibitor Sales in Volume by Country (2024-2029)
    • 9.2.2 Middle East and Africa Medical FLT3 Inhibitor Sales in Value by Country (2024-2029)

10 Company Profiles

  • 10.1 Cullinan Oncology
    • 10.1.1 Cullinan Oncology Company Information
    • 10.1.2 Cullinan Oncology Introduction and Business Overview
    • 10.1.3 Cullinan Oncology Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.1.4 Cullinan Oncology Medical FLT3 Inhibitor Products Offered
    • 10.1.5 Cullinan Oncology Recent Development
  • 10.2 Novartis
    • 10.2.1 Novartis Company Information
    • 10.2.2 Novartis Introduction and Business Overview
    • 10.2.3 Novartis Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.2.4 Novartis Medical FLT3 Inhibitor Products Offered
    • 10.2.5 Novartis Recent Development
  • 10.3 Astellas Pharma
    • 10.3.1 Astellas Pharma Company Information
    • 10.3.2 Astellas Pharma Introduction and Business Overview
    • 10.3.3 Astellas Pharma Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.3.4 Astellas Pharma Medical FLT3 Inhibitor Products Offered
    • 10.3.5 Astellas Pharma Recent Development
  • 10.4 Daiichi Sankyo
    • 10.4.1 Daiichi Sankyo Company Information
    • 10.4.2 Daiichi Sankyo Introduction and Business Overview
    • 10.4.3 Daiichi Sankyo Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.4.4 Daiichi Sankyo Medical FLT3 Inhibitor Products Offered
    • 10.4.5 Daiichi Sankyo Recent Development
  • 10.5 AROG Pharmaceuticals
    • 10.5.1 AROG Pharmaceuticals Company Information
    • 10.5.2 AROG Pharmaceuticals Introduction and Business Overview
    • 10.5.3 AROG Pharmaceuticals Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.5.4 AROG Pharmaceuticals Medical FLT3 Inhibitor Products Offered
    • 10.5.5 AROG Pharmaceuticals Recent Development
  • 10.6 Allarity Therapeutics
    • 10.6.1 Allarity Therapeutics Company Information
    • 10.6.2 Allarity Therapeutics Introduction and Business Overview
    • 10.6.3 Allarity Therapeutics Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.6.4 Allarity Therapeutics Medical FLT3 Inhibitor Products Offered
    • 10.6.5 Allarity Therapeutics Recent Development
  • 10.7 FUJIFILM Pharmaceuticals
    • 10.7.1 FUJIFILM Pharmaceuticals Company Information
    • 10.7.2 FUJIFILM Pharmaceuticals Introduction and Business Overview
    • 10.7.3 FUJIFILM Pharmaceuticals Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.7.4 FUJIFILM Pharmaceuticals Medical FLT3 Inhibitor Products Offered
    • 10.7.5 FUJIFILM Pharmaceuticals Recent Development
  • 10.8 Aptose Biosciences
    • 10.8.1 Aptose Biosciences Company Information
    • 10.8.2 Aptose Biosciences Introduction and Business Overview
    • 10.8.3 Aptose Biosciences Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.8.4 Aptose Biosciences Medical FLT3 Inhibitor Products Offered
    • 10.8.5 Aptose Biosciences Recent Development
  • 10.9 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
    • 10.9.1 CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Company Information
    • 10.9.2 CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Introduction and Business Overview
    • 10.9.3 CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.9.4 CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Medical FLT3 Inhibitor Products Offered
    • 10.9.5 CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Recent Development
  • 10.10 Jiangsu Hengrui Medicine
    • 10.10.1 Jiangsu Hengrui Medicine Company Information
    • 10.10.2 Jiangsu Hengrui Medicine Introduction and Business Overview
    • 10.10.3 Jiangsu Hengrui Medicine Medical FLT3 Inhibitor Sales, Revenue and Gross Margin (2018-2023)
    • 10.10.4 Jiangsu Hengrui Medicine Medical FLT3 Inhibitor Products Offered
    • 10.10.5 Jiangsu Hengrui Medicine Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

  • 11.1 Medical FLT3 Inhibitor Key Raw Materials
    • 11.1.1 Key Raw Materials
    • 11.1.2 Key Raw Materials Price
    • 11.1.3 Raw Materials Key Suppliers
  • 11.2 Manufacturing Cost Structure
    • 11.2.1 Raw Materials
    • 11.2.2 Labor Cost
    • 11.2.3 Manufacturing Expenses
  • 11.3 Medical FLT3 Inhibitor Industrial Chain Analysis
  • 11.4 Medical FLT3 Inhibitor Market Dynamics
    • 11.4.1 Medical FLT3 Inhibitor Industry Trends
    • 11.4.2 Medical FLT3 Inhibitor Market Drivers
    • 11.4.3 Medical FLT3 Inhibitor Market Challenges
    • 11.4.4 Medical FLT3 Inhibitor Market Restraints

12 Market Strategy Analysis, Distributors

  • 12.1 Sales Channel
  • 12.2 Medical FLT3 Inhibitor Distributors
  • 12.3 Medical FLT3 Inhibitor Downstream Customers

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer